tiprankstipranks
Immage Biotherapeutics Corp. (IMMG)
OTHER OTC:IMMG
US Market

Immage Biotherapeutics (IMMG) Financial Statements

0 Followers

Immage Biotherapeutics Financial Overview

Immage Biotherapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Immage Biotherapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 17Nov 16Aug 16May 16Feb 16
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit---$ 0.00-
EBIT$ -44.09K$ -1.67M$ -62.00K$ -50.86K$ -69.59K
EBITDA$ -41.96K$ -1.67M$ -60.41K$ -48.54K$ -67.28K
Net Income Common Stockholders$ -44.09K$ -1.67M$ -62.00K$ -50.86K$ -69.59K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 53.69K$ 127.14K$ 196.72K$ 265.49K$ 327.77K
Total Assets$ 90.81K$ 168.89K$ 243.10K$ 305.13K$ 369.72K
Total Debt$ 0.00$ 0.00$ 52.77K$ 0.00$ 0.00
Net Debt$ -53.69K$ -127.14K$ -143.95K$ -265.49K$ -327.77K
Total Liabilities$ 68.47K$ 102.46K$ 55.82K$ 55.85K$ 69.58K
Stockholders Equity$ 22.34K$ 66.44K$ 187.29K$ 249.28K$ 300.14K
Cash Flow-
Free Cash Flow$ -71.95K$ -71.08K$ -68.78K$ -62.28K$ -59.21K
Operating Cash Flow$ -71.95K$ -71.08K$ -68.78K$ -62.28K$ -59.21K
Investing Cash Flow-----
Financing Cash Flow$ -1.50K$ 1.50K$ 0.00$ 0.00$ 3.36K
Currency in USD

Immage Biotherapeutics Earnings and Revenue History

Immage Biotherapeutics Debt to Assets

Immage Biotherapeutics Cash Flow

Immage Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis